|
On 1 September 2023, the European Chemical Agency (ECHA) has launched a public consultation on 6 potential Substances of Very High Concern (SVHC). The proposed substances in the consultation are listed as below. The deadline for commenting is 16 October 2023.
| # |
Substance Name |
EC Number |
CAS Number |
Proposing Authority |
Reason for Proposing |
Uses(s) |
| 1 |
2,4,6-tri-tert-butylphenol (2,4,6-TTBP) |
211-989-5 |
732-26-3 |
Belgium |
Toxic for reproduction (Article 57(c));
PBT (Article 57(d));
vPvB (Article 57(e)) |
Fuel additives |
| 2 |
2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol
(UV-329) |
221-573-5 |
3147-75-9 |
Germany |
vPvB (Article 57(e)) |
Air care products, coating products, adhesives and sealants, lubricants and greases, polishes and waxes and washing & cleaning products |
| 3 |
2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one |
438-340-0 |
119344-86-4 |
Austria |
Toxic for reproduction (Article 57(c)) |
Coatings and inks |
| 4 |
Bumetrizole
(UV-326) |
223-445-4 |
3896-11-5 |
Germany |
vPvB (Article 57(e)) |
Coatings, adhesives, sealants, printing inks, polishes, and wax blends, textile dyes, finishing and impregnation products. Washing and cleaning products, fillers, putties, plasters, modelling clay, cosmetics, fragrances, air care products, biocidal products, photo-chemicals, and metal and non-metal surface treatment |
| 5 |
Dibutyl phthalate (DBP) |
201-557-4 |
84-74-2 |
Netherlands |
Endocrine disrupting properties (Article 57(f) - environment) |
Plasticiser, formulation in polymers and propellants |
| 6 |
Oligomerisation and alkylation reaction products of 2-phenylpropene and phenol (OAPP) |
700-960-7 |
-- |
Denmark |
vPvB (Article 57(e)) |
Adhesives and sealants, coating products, fillers, putties, plasters, modelling clay, inks and toners and polymers |
Note: Dibutyl phthalate (DBP) (CAS No. 84-74-2) has been included in the SVHC Candidate List on 28 October 2008. Its current intrinsic properties are toxic for reproduction (Article 57(c)), and endocrine disrupting properties (Article 57(f) - human health).
|
